Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• B+L and Technolas
• Ozurdex and BRVO
• Loteprednol etabonate reduces pain
• Adalimumab for uveitis
 
 
Survey

Would you use loteprednol etabonate gel after cataract surgery?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
February 6, 2013
B+L completes Technolas acquisition
Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier. More...
Ozurdex may be effective for BRVO prognosis
Ozurdex could have a beneficial effect on the visual prognosis in branch retinal vein occlusion (BRVO). More...
Gel cuts inflammation and pain
Loteprednol etabonate gel 0.5% is efficacious and safe for treating postoperative inflammation and pain caused by cataract surgery. More...
Adalimumab is effective uveitis treatment
Adalimumab is an effective treatment for patients with active non-infectious uveitis. More...